Opening discussion on the advent of differentiated thyroid cancer (DTC) and management, moderator Lori J. Wirth, MD, provides and overview of prevalence, subtypes, and prognosis.
Marcia Brose, MD, PhD, University of Pennsylvania
Advertisement
Articles by Marcia Brose, MD, PhD, University of Pennsylvania
Advertisement
Latest Updated Articles
Overview on Differentiated Thyroid Cancer (DTC)April 17th 2023
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
4
Sonrotoclax and Next-Generation BCL-2 Inhibitors for Treating CLL
5